@2024 Afarand., IRAN
ISSN: 2383-3483 Journal of Police Medicine 2019;8(2):69-73
ISSN: 2383-3483 Journal of Police Medicine 2019;8(2):69-73
A Comparison of Life Expectancy, Feelings of Guilt, and Psychosomatic Disorders between Revealing Female Addicts under Compulsory Treatment and Self-Introduced Female Addicts
ARTICLE INFO
Article Type
Original ResearchAuthors
Razavi R. (1)Arab A. (*)
Shirazi M. (2)
(*) Department of Psychology, Faculty of Psychology & Educational Sciences, niversity of Sistan and Baluchestan, Zahedan, Iran
(1) Department of Psychology, Faculty of Psychology & Educational Sciences, Zahedan Branch, Islamic Azad University, Zahedan, Iran
(2) Department of Psychology, Faculty of Psychology & Educational Sciences, University of Sistan and Baluchestan, Zahedan, Iran
Correspondence
Address: Sistan and Baluchestan University, Daneshgah Buolvared, Zahedan, IranPhone: -
Fax: -
aliarab@edpsy.usb.ac.ir
Article History
Received: November 12, 2018Accepted: January 20, 2019
ePublished: March 19, 2019
ABSTRACT
Aims
Addiction is a brain disorder that is caused by compulsion in rewards despite adverse consequences. This study aimed at comparing life expectancy, feelings of guilt, and psychosomatic disorders between revealing female addicts under compulsory treatment and self-introduced female addicts.
Materials & Methods This cross sectional study was conducted among revealing female addicts under compulsory treatment and self-introduced female addicts in Zahedan in 2018. Of each group, 30 cases were randomly selected as sample. Eysenck Feelings of Guilt Scale, Schneider Life Expectancy Inventory, and Takata and Sakata Psychosomatic Disorders were used to collect the data. The data were analyzed by SPSS 21, using multivariate analysis of variance.
Findings Mean score of life expectancy in revealing female addicts (30.36±8.68) was lower than that of the self-introduced female addicts (37.80±7.14; F=14.20; p<0.01). Mean score of feelings of guilt in revealing female addicts (18.80±2.44) was higher than that of the self-introduced female addicts (16.86±3.00; F=26.32; p<0.01). Also, mean score of psychosomatic disorders in revealing female addicts (58.30±8.78) was higher than that of the self-introduced female addicts (52.70±9.47; F=24.73; p<0.01).
Conclusion The revealing female addicts have lower levels of life expectancy, higher levels of feelings of guilt, and psychosomatic disorders in comparison to the self-introduced female addicts.
Materials & Methods This cross sectional study was conducted among revealing female addicts under compulsory treatment and self-introduced female addicts in Zahedan in 2018. Of each group, 30 cases were randomly selected as sample. Eysenck Feelings of Guilt Scale, Schneider Life Expectancy Inventory, and Takata and Sakata Psychosomatic Disorders were used to collect the data. The data were analyzed by SPSS 21, using multivariate analysis of variance.
Findings Mean score of life expectancy in revealing female addicts (30.36±8.68) was lower than that of the self-introduced female addicts (37.80±7.14; F=14.20; p<0.01). Mean score of feelings of guilt in revealing female addicts (18.80±2.44) was higher than that of the self-introduced female addicts (16.86±3.00; F=26.32; p<0.01). Also, mean score of psychosomatic disorders in revealing female addicts (58.30±8.78) was higher than that of the self-introduced female addicts (52.70±9.47; F=24.73; p<0.01).
Conclusion The revealing female addicts have lower levels of life expectancy, higher levels of feelings of guilt, and psychosomatic disorders in comparison to the self-introduced female addicts.
Keywords:
Life Expectancy,
Feelings of Guilt ,
Psychosomatic Disorders,
Revealing and Self-Introduced Female Addicts,
CITATION LINKS
[1]Volkow ND, Koob GF, Mclellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;347(4):363-71.
[2]Nestler EJ. Cellular basis of memory for addiction. Dialogues Clin Neurosci. 2013;15(4):431-43.
[3] Malenka RC, Nestler EJ, Hyman SE. Reinforcement and Addictive Disorders Molecular Neuropharafmacology afoundation for Clinical Neuroscie. 2nd edition. New York: McGraw-Hill Medical; 2009. pp. 364-75.
[4] Amodio M, Devine PG, Harmon-Jones E. A dynamic model of guilt: Implications for motivation and self-regulation in the context of prejudice. Psychol Sci. 2007;18(6):524-30.
[5] Cramer HL, Lauche R, Haller H, Langhorst J, Dobos G. Mindfulness- and acceptance-based interventions for psychosis: A systematic review and meta-analysis. Glob Adv Health Med. 2016;5(1):30-43.
[6]Naseri Polangerd S, Mohammadi F, Doleh M, Naseri M. Factors affecting addiction in women. Women Culture. 2011;4(16):83-94. [Persian]
[7]Harrington A, Dunne JD. When mindfulness is therapy: Ethical qualms, historical perspectives. Am Psychol. 2015;70(7):621-31.
[8]Malayeri Khah Langerodi Z, Rahimi Moghar A, Younessian M, Delbar Pour Ahmadi Sh, Shariaty M. Social problems of wives of addicted men in the area covered by the health center of east Tehran. Soc Welfare. 2008;7(29):109-23. [Persian]
[9] Zapolski TC, Cyders MA, Smith GT. Positiye urgency predicts illegal drug use and risky sexual behaviar. Psychol Addict Behav. 2009;23(2):348-54.
[10]E Van Dongen. I wish a happy end; hope in the lives of chronic schizophrenic patients. Anthropol Med. 1998;5(2):169-92.
[11]McClement SE, Chochinov HM. Hope in advanced cancer patients. Eur J Canser. 2008;44(8):1169-74.
[12]Querstret D, Cropley M. Assessing treatments used to reduce rumination and/or worry: A systematic review. Clin Psychol Rev. 2013;33(8):996-1009.
[13]Ravndal E, Vaglum M. Psychopathology, treatment completion and 5 years outcome: A prospective study of drug abusers. J Subst Abuse Treat. 1998;15(2):135-42.
[14]Cyders MA, Smith GT. Emotion–based dispositions to rash action positive and negative urgency. Psychol Bull. 2008;134(6):807-28.
[15]Aust JB, Bradshaw T. Mindfulness interventions for psychosis: A systematic review of the literature. J Psychiatr Ment Health Nurs. 2017;24(1):69-83.
[16]Creswell JD. Mindfulness intervention. Ann Rev Psychol. 2017;68:491-516.
[17]shabbeh Z, Feizi A, Afshar H, Hassanzade Kashtali A, Adibi P. Identifying the profiles of psychosomatic disorders in an iranian adult population and their relation to psychological problems. J Mazandaran Univ Med Sci. 2016;26(137):82-94. [Persian]
[18]Brondani M, Park PE. Methadone and oral health: A brief review. J Dent Hyg. 2011;85(2):92-8.
[19]Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1-3):280-95.
[20]Malenka RC, Nastler EJ, Hyman SE, Holtzman DM. CHAPTER 16: Reinforcement and addictive disorders. In: Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. Nestler EJ, Hyman SE, Holtzman DM, Malenka RC, editors. New York: McGraw-Hill Medical; 2015.
[21]Brocka M, Helbing C, Vincenz D, Scherf T, Montag D, Goldschmidt J, et al. Contributions of dopaminergic and non-dopaminergic neurons to VTA-stimulation induced neurovascular responses in brain reward circuits. Neuroimage. 2018;177:88-97.
[22]Mathuru AS. A little rein on addiction. Semin Cell Dev Biol. 2018;78:120-9.
[23]Heather N. Is the concept of compulsion useful in the explanation or description of addictive behaviour and experience?. Addict Behav Rep. 2017;6:15-38.
[2]Nestler EJ. Cellular basis of memory for addiction. Dialogues Clin Neurosci. 2013;15(4):431-43.
[3] Malenka RC, Nestler EJ, Hyman SE. Reinforcement and Addictive Disorders Molecular Neuropharafmacology afoundation for Clinical Neuroscie. 2nd edition. New York: McGraw-Hill Medical; 2009. pp. 364-75.
[4] Amodio M, Devine PG, Harmon-Jones E. A dynamic model of guilt: Implications for motivation and self-regulation in the context of prejudice. Psychol Sci. 2007;18(6):524-30.
[5] Cramer HL, Lauche R, Haller H, Langhorst J, Dobos G. Mindfulness- and acceptance-based interventions for psychosis: A systematic review and meta-analysis. Glob Adv Health Med. 2016;5(1):30-43.
[6]Naseri Polangerd S, Mohammadi F, Doleh M, Naseri M. Factors affecting addiction in women. Women Culture. 2011;4(16):83-94. [Persian]
[7]Harrington A, Dunne JD. When mindfulness is therapy: Ethical qualms, historical perspectives. Am Psychol. 2015;70(7):621-31.
[8]Malayeri Khah Langerodi Z, Rahimi Moghar A, Younessian M, Delbar Pour Ahmadi Sh, Shariaty M. Social problems of wives of addicted men in the area covered by the health center of east Tehran. Soc Welfare. 2008;7(29):109-23. [Persian]
[9] Zapolski TC, Cyders MA, Smith GT. Positiye urgency predicts illegal drug use and risky sexual behaviar. Psychol Addict Behav. 2009;23(2):348-54.
[10]E Van Dongen. I wish a happy end; hope in the lives of chronic schizophrenic patients. Anthropol Med. 1998;5(2):169-92.
[11]McClement SE, Chochinov HM. Hope in advanced cancer patients. Eur J Canser. 2008;44(8):1169-74.
[12]Querstret D, Cropley M. Assessing treatments used to reduce rumination and/or worry: A systematic review. Clin Psychol Rev. 2013;33(8):996-1009.
[13]Ravndal E, Vaglum M. Psychopathology, treatment completion and 5 years outcome: A prospective study of drug abusers. J Subst Abuse Treat. 1998;15(2):135-42.
[14]Cyders MA, Smith GT. Emotion–based dispositions to rash action positive and negative urgency. Psychol Bull. 2008;134(6):807-28.
[15]Aust JB, Bradshaw T. Mindfulness interventions for psychosis: A systematic review of the literature. J Psychiatr Ment Health Nurs. 2017;24(1):69-83.
[16]Creswell JD. Mindfulness intervention. Ann Rev Psychol. 2017;68:491-516.
[17]shabbeh Z, Feizi A, Afshar H, Hassanzade Kashtali A, Adibi P. Identifying the profiles of psychosomatic disorders in an iranian adult population and their relation to psychological problems. J Mazandaran Univ Med Sci. 2016;26(137):82-94. [Persian]
[18]Brondani M, Park PE. Methadone and oral health: A brief review. J Dent Hyg. 2011;85(2):92-8.
[19]Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1-3):280-95.
[20]Malenka RC, Nastler EJ, Hyman SE, Holtzman DM. CHAPTER 16: Reinforcement and addictive disorders. In: Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. Nestler EJ, Hyman SE, Holtzman DM, Malenka RC, editors. New York: McGraw-Hill Medical; 2015.
[21]Brocka M, Helbing C, Vincenz D, Scherf T, Montag D, Goldschmidt J, et al. Contributions of dopaminergic and non-dopaminergic neurons to VTA-stimulation induced neurovascular responses in brain reward circuits. Neuroimage. 2018;177:88-97.
[22]Mathuru AS. A little rein on addiction. Semin Cell Dev Biol. 2018;78:120-9.
[23]Heather N. Is the concept of compulsion useful in the explanation or description of addictive behaviour and experience?. Addict Behav Rep. 2017;6:15-38.